Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chan He

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Clinical and Experimental Medicine|January 14, 2010
CK20 and Ki-67 as significant prognostic factors in human bladder carcinomaYong-kang Ye, Xue-cheng Bi, Hui-chan He, et al.
Oncotargets and Therapy|February 5, 2014
Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancerGuo-Qiang Qin, Hui-Chan He, Zhao-Dong Han, et al.
Oncology Reports|March 28, 2015
Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancerYu-Xiang Liang, Ru-Jun Mo, Hui-Chan He, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 15, 2014
MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancerHao Fu, Hui-chan He, Zhao-dong Han, et al.
Journal of Chemotherapy (Florence, Italy)|January 15, 2010
Pathogen incidence and antibiotic resistance patterns of catheter-associated urinary tract infection in childrenXue-Cheng Bi, Binghua Zhang, Yong-Kang Ye, et al.
International Urology and Nephrology|February 19, 2017
High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancerJian-Jiang Xie, Yang-Jia Zhuo, Yu Zheng, et al.
Genomics|September 12, 2020
Polymorphisms in matricellular SPP1 and SPARC contribute to susceptibility to papillary thyroid cancerXuan Su, Bo-Heng Xu, Da-Lei Zhou, et al.
Cancer Investigation|June 24, 2009
CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic valueYu-Xiang Liang, Hui-Chan He, Zhao-Dong Han, et al.
Pathology Oncology Research : POR|December 3, 2008
CD147 expression indicates unfavourable prognosis in prostate cancerZhao-dong Han, Xue-cheng Bi, Wei-jun Qin, et al.
Journal of Cellular Biochemistry|May 26, 2018
Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancerYing-Ke Liang, Zhao-Dong Han, Jian-Ming Lu, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Clinical and Experimental Medicine|January 14, 2010
CK20 and Ki-67 as significant prognostic factors in human bladder carcinomaYong-kang Ye, Xue-cheng Bi, Hui-chan He, et al.
Oncotargets and Therapy|February 5, 2014
Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancerGuo-Qiang Qin, Hui-Chan He, Zhao-Dong Han, et al.
Oncology Reports|March 28, 2015
Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancerYu-Xiang Liang, Ru-Jun Mo, Hui-Chan He, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 15, 2014
MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancerHao Fu, Hui-chan He, Zhao-dong Han, et al.
Journal of Chemotherapy (Florence, Italy)|January 15, 2010
Pathogen incidence and antibiotic resistance patterns of catheter-associated urinary tract infection in childrenXue-Cheng Bi, Binghua Zhang, Yong-Kang Ye, et al.
International Urology and Nephrology|February 19, 2017
High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancerJian-Jiang Xie, Yang-Jia Zhuo, Yu Zheng, et al.
Genomics|September 12, 2020
Polymorphisms in matricellular SPP1 and SPARC contribute to susceptibility to papillary thyroid cancerXuan Su, Bo-Heng Xu, Da-Lei Zhou, et al.
Cancer Investigation|June 24, 2009
CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic valueYu-Xiang Liang, Hui-Chan He, Zhao-Dong Han, et al.
Pathology Oncology Research : POR|December 3, 2008
CD147 expression indicates unfavourable prognosis in prostate cancerZhao-dong Han, Xue-cheng Bi, Wei-jun Qin, et al.
Journal of Cellular Biochemistry|May 26, 2018
Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancerYing-Ke Liang, Zhao-Dong Han, Jian-Ming Lu, et al.
Pageof 10